Biblio
The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma. Cell Stem Cell. 2020.
pERK1/2 Peripheral Recruitment and Filopodia Protrusion Augment Oligodendrocyte Progenitor Cell Migration: Combined Effects of PDGF-A and Fibronectin. Cell Mol Neurobiol. 2016.
. Intratumoral Delivery of Chimeric Antigen Receptor-T Cells Targeting CD133 Effectively Treats Brain Metastases. Clin Cancer Res. 2023.
Development of a peptide-based delivery platform for targeting malignant brain tumors. Biomaterials. 2020;252:120105.
Culture and Isolation of Brain Tumor Initiating Cells. Curr Protoc Stem Cell Biol. 2015;34:3.3.1-3.3.13.
. Characterization of the minimal residual disease state reveals distinct evolutionary trajectories of human glioblastoma. Cell Rep. 2022;40(13):111420.